Etomidate: A Powerful Anaesthetic Agent with Benefits and Risks
Etomidate is a short-acting intravenous anaesthetic drug widely used in emergency and critical care medicine. It has unique advantages in certain clinical settings but also comes with important limitations and safety concerns.
What is Etomidate?
Etomidate is an intravenous sedative-hypnotic agent. It is not a painkiller but rather a drug used to induce unconsciousness quickly and safely. In hospitals, it is commonly used for:
- Rapid Sequence Intubation (RSI): Quickly sedating patients so doctors can insert a breathing tube.
- Anaesthetic induction: Putting patients to sleep before surgery.
- Procedural sedation: In selected short procedures where rapid sedation is required.
Why Do Doctors Use Etomidate?
The main advantage of etomidate is its cardiovascular stability. Unlike other anaesthetic drugs (such as propofol), etomidate has minimal effects on blood pressure and heart rate. This makes it especially useful for patients who are:
- Critically ill
- In shock
- With unstable heart conditions
It also has a rapid onset (within 30–60 seconds) and short duration of action (about 5–10 minutes), allowing clinicians to quickly control the airway and then transition to other sedatives.
Risks and Side Effects
Despite its benefits, etomidate has important drawbacks:
- Adrenal suppression: It inhibits the production of cortisol (a stress hormone), which can be dangerous if prolonged. This is why it is usually limited to single-dose use rather than continuous infusion.
- Nausea and vomiting are common after use.
- Myoclonus (involuntary muscle jerks) may occur during induction.
- No pain relief: Since etomidate has no analgesic properties, it is usually combined with painkillers in emergency settings.
Etomidate Outside Medicine
In recent years, etomidate has been misused when illegally added to vape liquids (so-called “Kpods”). This poses significant health dangers because the drug is potent, uncontrolled, and unsafe outside medical supervision. Many countries, including Singapore, are moving to classify etomidate as a controlled substance due to its misuse potential.
Etomidate remains a valuable tool in medicine—particularly for critically ill patients needing safe, rapid sedation. However, its risks, especially adrenal suppression, mean that it must be used judiciously by trained professionals. Its appearance in illicit vape products highlights the importance of regulating medical substances to prevent dangerous misuse.
